메디앙스

014100KOSDAQ상품 종합 도매업

57.8 / 100

Reference Date: 2026-06-10

Financial Score18.5 / 40

News Sentiment21.3 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Declined 14.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Medians is a total culture company for infants, offering scientific products such as skincare, nursing items, and fashion under the motto 'Another name for mom.' Key brands include Dr.ato, The Pure, and Chocolat, while the company has expanded globally by establishing subsidiaries in China, such as Tianjin and Meijie, to drive growth.

Number of Employees

93people

Average Salary

49.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 8.304.0Point

PBR

0.25Industry Average 0.527.0Point

Half of industry avg (excellent)

ROE

-8.48Industry Average -1.663.5Point

5.1x industry avg (excellent)

Debt Ratio

14.60Industry Average 14.604.0Point

In line with industry avg

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼13.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼247.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -5.8% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 6Neutral 0Negative 0Average Sentiment Score 85

Positive
메디앙스 비앤비, 중국 유통 채널 확대...‘아이잉스·용후이’ 공급.....
메디앙스의 중국 내 유아용품 유통 채널 확대 전략이 현지 시장 점유율 강화에 기여할 것으로 예상됩니다.
Positive
메디앙스 비앤비, 중국 유아용품 플랫폼 '하이즈왕' 공급 확대…유아.....
메디앙스는 중국 유아용품 플랫폼 하이즈왕을 통해 현지 유아동 시장 점유율 확대를 추진하며 중국 사업 성장에 긍정적 영향을 미치고 있다.
Positive
메디앙스 B&B, 월마트 계열 샘스클럽 입점 확대…글로벌 매출 성장 본...
메디앙스의 샘스클럽 입점 확대로 중국 프리미엄 시장 공략 강화, 긍정적 성장 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 1,469Won52-week high 2,23052-week low 1,392

1-month return1.0Point

1m -14.84% (falling)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-05-29
Neutral분기보고서 (2026.03)2026-05-15